Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observational real-world cohort study

Klemen Dovc; Michelle Van Name; Barbara Jenko Bizjan; Ewa Rusak; Claudia Piona; Gul Yesiltepe-Mutlu; Rosaline Mentink; Giulio Frontino; Maddalena Macedoni; Sofia Helena Ferreira; Joana Serra-Caetano; Júlia Galhardo; Julie Pelicand; Francesca Silvestri; Jennifer Sherr; Agata Chobot; Torben Biester

doi:10.1111/dom.14607

Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observational real-world cohort study

Klemen Dovc, Michelle Van Name, Barbara Jenko Bizjan, Ewa Rusak, Claudia Piona, Gul Yesiltepe-Mutlu, Rosaline Mentink, Giulio Frontino, Maddalena Macedoni, Sofia Helena Ferreira, Joana Serra-Caetano, Júlia Galhardo, Julie Pelicand, Francesca Silvestri, Jennifer Sherr, Agata Chobot, Torben Biester

NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)

Research output: Contribution to journal › Letter › peer-review

7 Citations (Scopus)

36 Downloads (Pure)

Original language	English
Pages (from-to)	564 - 569
Journal	Diabetes, Obesity and Metabolism
Volume	24
Issue number	3
Early online date	2021
DOIs	https://doi.org/10.1111/dom.14607
Publication status	Published - Mar 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/dom.14607Licence: CC BY

Diabetes Obesity Metabolism - 2021 - Dovc - Continuous glucose monitoring use and glucose variability in very youngFinal published version, 1.21 MBLicence: CC BY

Cite this

Dovc, K., Van Name, M., Jenko Bizjan, B., Rusak, E., Piona, C., Yesiltepe-Mutlu, G., Mentink, R., Frontino, G., Macedoni, M., Ferreira, S. H., Serra-Caetano, J., Galhardo, J., Pelicand, J., Silvestri, F., Sherr, J., Chobot, A., & Biester, T. (2022). Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observational real-world cohort study. Diabetes, Obesity and Metabolism, 24(3), 564 - 569. https://doi.org/10.1111/dom.14607

@article{9b338a1678c34a22801db8ec4f34e160,

title = "Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observational real-world cohort study",

author = "Klemen Dovc and {Van Name}, Michelle and {Jenko Bizjan}, Barbara and Ewa Rusak and Claudia Piona and Gul Yesiltepe-Mutlu and Rosaline Mentink and Giulio Frontino and Maddalena Macedoni and Ferreira, {Sofia Helena} and Joana Serra-Caetano and J{\'u}lia Galhardo and Julie Pelicand and Francesca Silvestri and Jennifer Sherr and Agata Chobot and Torben Biester",

note = "Funding Information: The authors thank the ISPAD executive committee and ISPAD JENIOUS members for their support. An abstract with partial study data was presented in June 2021 at the Virtual Advanced Technologies and Treatment for Diabetes (ATTD) conference. There was no commercial sponsor for this study. This study was partially funded by the ISPAD JDRF Fellowship Grant. KD was supported by the Slovenian National Research Agency (grant nos. J3–6798, V3–1505, and P3–0343). Funding Information: ISPAD, Grant/Award Number: ISPAD JDRF Fellowship Grant; Slovenian National Research Agency, Grant/Award Numbers: J36798, V31505, P30343 Funding information Funding Information: KD received honoraria for participation on the speakerʼs bureau of Pfizer, Novo Nordisk, and Eli Lilly. JG received speakerʼs honoraria from Eli Lilly and Sanofi, and clinical trials investigatorʼs payment from Novo Nordisk. RM received advisory board honoraria from Abbott and Novo Nordisk. JP received speakerʼs honoraria from Medtronic. JS serves as a consultant to Cecelia Health, Lexicon, Lilly, Insulet, Medtronic, and Sanofi, is a member of the advisory board for Bigfoot Biomedical, Cecelia Health, Insulet, Medtronic, and the T1D Fund and Vertex, and has had research support from the NIH, JDRF, and the Helmsley Charitable Trust. Her institution has had research support from Medtronic and Insulet. AC received speakerʼs honoraria from Medtronic, Eli Lilly, and Novo Nordisk. TB received speakerʼs honoraria from DexCom, Medtronic, Novo Nordisk, Roche, Sanofi, and Ypsomed, and advisory board honoraria from Ascensia, AstraZeneca, DexCom, Medtronic, and Sanofi. ",

year = "2022",

month = mar,

doi = "10.1111/dom.14607",

language = "English",

volume = "24",

pages = "564 -- 569",

journal = "Diabetes, obesity & metabolism",

issn = "1462-8902",

publisher = "Wiley",

number = "3",

}

Dovc, K, Van Name, M, Jenko Bizjan, B, Rusak, E, Piona, C, Yesiltepe-Mutlu, G, Mentink, R, Frontino, G, Macedoni, M, Ferreira, SH, Serra-Caetano, J, Galhardo, J, Pelicand, J, Silvestri, F, Sherr, J, Chobot, A & Biester, T 2022, 'Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observational real-world cohort study', Diabetes, Obesity and Metabolism, vol. 24, no. 3, pp. 564 - 569. https://doi.org/10.1111/dom.14607

Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observational real-world cohort study. / Dovc, Klemen; Van Name, Michelle; Jenko Bizjan, Barbara et al.
In: Diabetes, Obesity and Metabolism, Vol. 24, No. 3, 03.2022, p. 564 - 569.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate)

T2 - A multinational prospective observational real-world cohort study

AU - Dovc, Klemen

AU - Van Name, Michelle

AU - Jenko Bizjan, Barbara

AU - Rusak, Ewa

AU - Piona, Claudia

AU - Yesiltepe-Mutlu, Gul

AU - Mentink, Rosaline

AU - Frontino, Giulio

AU - Macedoni, Maddalena

AU - Ferreira, Sofia Helena

AU - Serra-Caetano, Joana

AU - Galhardo, Júlia

AU - Pelicand, Julie

AU - Silvestri, Francesca

AU - Sherr, Jennifer

AU - Chobot, Agata

AU - Biester, Torben

N1 - Funding Information: The authors thank the ISPAD executive committee and ISPAD JENIOUS members for their support. An abstract with partial study data was presented in June 2021 at the Virtual Advanced Technologies and Treatment for Diabetes (ATTD) conference. There was no commercial sponsor for this study. This study was partially funded by the ISPAD JDRF Fellowship Grant. KD was supported by the Slovenian National Research Agency (grant nos. J3–6798, V3–1505, and P3–0343). Funding Information: ISPAD, Grant/Award Number: ISPAD JDRF Fellowship Grant; Slovenian National Research Agency, Grant/Award Numbers: J36798, V31505, P30343 Funding information Funding Information: KD received honoraria for participation on the speakerʼs bureau of Pfizer, Novo Nordisk, and Eli Lilly. JG received speakerʼs honoraria from Eli Lilly and Sanofi, and clinical trials investigatorʼs payment from Novo Nordisk. RM received advisory board honoraria from Abbott and Novo Nordisk. JP received speakerʼs honoraria from Medtronic. JS serves as a consultant to Cecelia Health, Lexicon, Lilly, Insulet, Medtronic, and Sanofi, is a member of the advisory board for Bigfoot Biomedical, Cecelia Health, Insulet, Medtronic, and the T1D Fund and Vertex, and has had research support from the NIH, JDRF, and the Helmsley Charitable Trust. Her institution has had research support from Medtronic and Insulet. AC received speakerʼs honoraria from Medtronic, Eli Lilly, and Novo Nordisk. TB received speakerʼs honoraria from DexCom, Medtronic, Novo Nordisk, Roche, Sanofi, and Ypsomed, and advisory board honoraria from Ascensia, AstraZeneca, DexCom, Medtronic, and Sanofi.

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85121806695&partnerID=8YFLogxK

U2 - 10.1111/dom.14607

DO - 10.1111/dom.14607

M3 - Letter

AN - SCOPUS:85121806695

SN - 1462-8902

VL - 24

SP - 564

EP - 569

JO - Diabetes, obesity & metabolism

JF - Diabetes, obesity & metabolism

IS - 3

ER -

Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observational real-world cohort study

UN SDGs

Access to Document

Other files and links

Cite this